keyword
MENU ▼
Read by QxMD icon Read
search

Borderline ovarian tumor

keyword
https://www.readbyqxmd.com/read/29682098/testing-for-nras-mutations-in-serous-borderline-ovarian-tumors-and-low-grade-serous-ovarian-carcinomas
#1
Pawel Sadlecki, Dariusz Grzanka, Marek Grabiec
The Idylla NRAS Mutation Test , performed on the Biocartis Idylla system, is an in vitro diagnostic tool for the qualitative assessment of 18 NRAS mutations in codons 12, 13, 59, 61, 117, and 146. Low-grade serous ovarian cancer (LGSC) represents less than 10% of all serous ovarian carcinomas. LGSCs are believed to arise from preexisting cystadenomas or serous borderline tumors (SBOTs) that eventually progress to an invasive carcinoma. The molecular analysis of cancer-causing mutations and the development of targeted biological therapies constitute a milestone in the diagnosis and therapy of ovarian malignancies...
2018: Disease Markers
https://www.readbyqxmd.com/read/29680231/accuracy-of-intraoperative-frozen-section-diagnosis-of-borderline-ovarian-tumors-by-hospital-type
#2
Jaimin Shah, Michael Mackelvie, David M Gershenson, Preetha Ramalingam, Marylee M Kott, Jubilee Brown, Polly Gauthier, Elizabeth Nugent, Lois M Ramondetta, M Frumovitz
STUDY OBJECTIVE: To compare the accuracy of frozen section diagnosis of borderline ovarian tumors among three distinct types of hospital-academic hospital with gynecologic pathologists, academic hospital with non-gynecologic pathologists, and community hospital with non-gynecologic pathologists-and to determine if surgical staging alters patient care or outcomes for women with a frozen section diagnosis of borderline ovarian tumor. DESIGN: Retrospective study DESIGN CLASSIFICATION: Level II1 SETTING: Tertiary care, academic, and community hospitals PATIENTS: Women with an intraoperative frozen section diagnosis of borderline ovarian tumor at one of the aforementioned three types of hospital from April 1998 through June 2016...
April 19, 2018: Journal of Minimally Invasive Gynecology
https://www.readbyqxmd.com/read/29676373/ovarian-borderline-mucinous-tumor-with-squamous-overgrowth-an-unusual-finding-with-review-of-literature
#3
Geetha Vasudevan, Padmapriya Jaiprakash, Shyamala Guruvare, Nivedita Samanta
Borderline mucinous tumor (BMT) is often associated with other entities such as dermoid cyst, Brenner tumor, and endometriosis. Squamous areas are often associated which may be a part of BMT or its associated conditions. Here, we describe squamous overgrowth in a case of intestinal type of mucinous borderline tumor in a 29-year-old uniparous female and discuss the diagnostic difficulties.
April 2018: Indian Journal of Pathology & Microbiology
https://www.readbyqxmd.com/read/29673382/risk-of-synchronous-endometrial-disorders-in-women-with-endometrioid-borderline-tumors-of-the-ovary
#4
Shuang-Zheng Jia, Jun-Ji Zhang, Jun-Jun Yang, Yang Xiang, Zhiyong Liang, Jin-Hua Leng
BACKGROUND: Synchronous endometrial disorders have been poorly studied in women with endometrioid borderline ovarian tumors (EBOT). The aims of this study were to investigate the risk of endometrial disorders among women with EBOT and associated factors, as well as their oncological and fertility outcomes. RESULTS: This retrospective study included 33 women with EBOT. Their mean age was 41.9 years, and endometria were evaluated in 25 of these patients. The prevalence of synchronous endometrial disorders was 52...
April 19, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29593930/mucinous-carcinomatosis-a-rare-association-between-an-ovarian-tumor-and-an-e-gist
#5
Hugo Palma Rios, André Goulart, Pedro Leão
Pseudomyxoma peritonei (PMP) and extragastrointestinal stromal tumors (E-GISTs) are both rare entities. Most of the time, PMP is associated with an appendiceal tumor. An ovarian mucinous tumor can mimic appendiceal metastases. E-GIST is a mesenchymal tumor that can arise from the omentum, retroperitoneum, mesentery, or pleura. We present a case of an 87-year-old woman with mucinous carcinomatosis and acute intestinal occlusion submitted to an emergency laparotomy. She has found to have a borderline mucinous tumor of the ovary from the intestinal type with several lesions of pseudomyxoma peritonei and an E-GIST from the epiploons retrocavity (intermediated risk)...
2018: Case Reports in Surgery
https://www.readbyqxmd.com/read/29581788/increased-he4-mrna-expression-correlates-with-high-level-of-eif3a-mrna-and-better-survival-in-women-with-epithelial-ovarian-cancer
#6
Chen-Hui Luo, Min Zhao, Yu-Xi Tang, Shohreh Shahabi, Kai-Ning Fang, Yan Chen, Yan Tang, Xiao-Yan Chen, Jing Wang, Hong-Hao Zhou
Human epididymis protein 4 (HE4) is one of the most promising biomarkers for epithelial ovarian cancer (EOC). The majority of previous studies utilized the serum level or tissue protein expression of HE4 based upon immunohistochemistry (IHC) to evaluate the role of HE4 in the diagnosis, prognosis, and surveillance of EOC, but very little is known about HE4 mRNA expression. Eukaryotic translation initiation factor 3a (eIF3a) is implicated in oncogenesis and has been investigated extensively as a potential biomarker for malignancy...
2018: Journal of Cancer
https://www.readbyqxmd.com/read/29571946/nilotinib-in-locally-advanced-pigmented-villonodular-synovitis-a-multicentre-open-label-single-arm-phase-2-trial
#7
Hans Gelderblom, Claire Cropet, Christine Chevreau, Richard Boyle, Martin Tattersall, Silvia Stacchiotti, Antoine Italiano, Sophie Piperno-Neumann, Axel Le Cesne, Virginia Ferraresi, Nicolas Penel, Florence Duffaud, Philippe Cassier, Maud Toulmonde, Paolo Casali, Sophie Taieb, Séverine Guillemaut, Séverine Metzger, David Pérol, Jean-Yves Blay
BACKGROUND: Pigmented villonodular synovitis (alternatively known as diffuse-type giant cell tumour) is a rare, locally aggressive tumour driven by a specific translocation resulting in the overexpression of colony-stimulating factor 1 (CSF1). CSF1 receptor (CSF1R) inhibitors (ie, tyrosine kinase inhibitors and antibodies) induce a response in patients with pigmented villonodular synovitis. We investigated the safety and efficacy of a CSF1R tyrosine kinase inhibitor, nilotinib, in patients with locally advanced non-resectable pigmented villonodular synovitis...
March 20, 2018: Lancet Oncology
https://www.readbyqxmd.com/read/29556691/quantitative-dynamic-contrast-enhanced-mr-imaging-for-differentiating-benign-borderline-and-malignant-ovarian-tumors
#8
Hai-Ming Li, Feng Feng, Jin-Wei Qiang, Guo-Fu Zhang, Shu-Hui Zhao, Feng-Hua Ma, Yong-Ai Li, Wei-Yong Gu
PURPOSE: This study aimed to investigate the diagnostic performance of quantitative DCE-MRI for characterizing ovarian tumors. METHODS: We prospectively assessed the differences of quantitative DCE-MRI parameters (Ktrans , kep , and ve ) among 15 benign, 28 borderline, and 66 malignant ovarian tumors; and between type I (n = 28) and type II (n = 29) of epithelial ovarian carcinomas (EOCs). DCE-MRI data were analyzed using whole solid tumor volume region of interest (ROI) method, and quantitative parameters were calculated based on a modified Tofts model...
March 20, 2018: Abdominal Radiology
https://www.readbyqxmd.com/read/29552194/activation-of-hedgehog-signaling-and-its-association-with-cisplatin-resistance-in-ovarian-epithelial-tumors
#9
Xueling Song, Liying Yan, Cuiling Lu, Chunyu Zhang, Fuli Zhu, Jingjing Yang, Hongyan Jing, Yang Zhang, Jie Qiao, Hongyan Guo
Few studies have evaluated Hedgehog (Hh) signaling pathway activation in different types of ovarian tumors including benign, borderline and malignant ovarian tumors. The present study investigated the expression of Hh signaling pathway components (SHH, SMO, PTCH, and GLI1) in 193 ovarian epithelial tumor specimens (including 147 malignant epithelial ovarian cancers, 30 borderline ovarian tumors, 16 benign ovarian epithelial tumors) and 11 normal ovarian epithelial tissues by immunohistochemistry. The results demonstrated widespread expression of Hh pathway molecules in ovarian tumors...
April 2018: Oncology Letters
https://www.readbyqxmd.com/read/29551085/ovarian-clear-cell-adenofibroma-of-low-malignant-potential-developing-into-clear-cell-adenocarcinoma
#10
Zhiwei Yin, Stephen Peters, Ravi Chokshi, Debra Heller
Ovarian clear cell adenofibroma is uncommon, and borderline clear cell adenofibroma (low malignant potential) is extremely rare. Borderline clear cell adenofibromas may represent the precursor lesion of clear cell adenocarcinoma of the ovary, but this has not been established. We present a case of a woman in her mid-50s with a clear cell adenofibroma ranging from benign to borderline to frankly invasive. While some clear cell adenocarcinomas are thought to arise from endometriosis, this range of findings supports the theory that some ovarian clear cell adenocarcinomas originate from borderline tumors...
March 1, 2018: International Journal of Surgical Pathology
https://www.readbyqxmd.com/read/29545041/testis-tumor-of-ovarian-epithelial-type-a-rare-case
#11
Kamleshsingh Shadhu, Dadhija Ramlagun, Kai Zhu, Yao Zhang, Chen Chen, Di Xi, Jundong Zhu, Chenkui Miao, Yichun Wang, Chao Qin
Ovarian epithelial type tumors of the testis have been a rare entity in clinic. Its' awareness and management remain a clinical challenge. We described a case of an 18-year-old, obese, boy who presented with scrotal enlargement. He underwent eversion of tunica vaginalis and resection of epidydimal mass. The histology of the resected sample showed ovarian epithelial type borderline tumor. We believe this case helps to strengthen awareness and management of this rare disease.
March 12, 2018: Urology
https://www.readbyqxmd.com/read/29520665/report-of-the-survey-on-current-opinions-and-practice-of-german-society-for-gynecologic-endoscopy-age-members-regarding-the-laparoscopic-treatment-of-ovarian-malignancies
#12
Julia Caroline Radosa, Marc Philipp Radosa, Pascal Albert Schweitzer, Ingolf Juhasz-Boess, Stefan Rimbach, Erich-Franz Solomayer
PURPOSE: The purpose of this survey was to assess the opinions of members of the German Society of Gynecologic Endoscopy (AGE) regarding the laparoscopic treatment of ovarian malignancies and current practice at their institutions. METHODS: Between February and October 2015, the AGE sent an anonymous online survey via mail to its members. The questionnaire solicited participants' opinions about the laparoscopic treatment of ovarian cancers according to T stage and borderline tumors, and information about current practice at their institutions...
March 8, 2018: Archives of Gynecology and Obstetrics
https://www.readbyqxmd.com/read/29491083/characterization-and-management-of-borderline-ovarian-tumors-results-of-a-retrospective-single-center-study-of-patients-treated-at-the-department-of-gynecology-and-obstetrics-of-the-university-medicine-greifswald
#13
Dominique Koensgen, Martin Weiss, Kathrin Assmann, Sara Y Brucker, Diethelm Wallwiener, Matthias B Stope, Alexander Mustea
BACKGROUND/AIM: Borderline ovarian tumors (BOT) are malignant epithelial ovarian tumors with a very low incidence, therefore lacking sufficient clinical experience in diagnostics and treatment. This study characterized the histology, clinical features, diagnostics and therapy of BOT including patients treated at the Department of Gynecology and Obstetrics of the University Medicine Greifswald. MATERIALS AND METHODS: In this retrospective, single-center study, patients with BOT treated between 1990 and 2010 were analyzed according to their histological and clinical reports...
March 2018: Anticancer Research
https://www.readbyqxmd.com/read/29489407/ct-features-of-ovarian-tumors-defining-key-differences-between-serous-borderline-tumors-and-low-grade-serous-carcinomas
#14
Stephanie Nougaret, Yulia Lakhman, Nicolas Molinari, Diana Feier, Chiara Scelzo, Hebert A Vargas, Ramon E Sosa, Hedvig Hricak, Robert A Soslow, Rachel N Grisham, Evis Sala
OBJECTIVE: The objective of our study was to investigate whether the CT features of serous borderline tumors (SBTs) differ from those of low-grade serous carcinomas (LGSCs) and to evaluate if mutation status is associated with distinct CT phenotypes. MATERIALS AND METHODS: This retrospective study included 59 women, 37 with SBT and 22 with LGSC, who underwent CT before primary surgical resection. Thirty of 59 patients were genetically profiled. Two radiologists (readers 1 and 2) independently and retrospectively reviewed CT examinations for qualitative features and quantified total tumor volumes (TTVs), solid tumor volumes (STVs), and solid proportion of ovarian masses...
February 28, 2018: AJR. American Journal of Roentgenology
https://www.readbyqxmd.com/read/29487003/satb2-is-a-supportive-marker-for-the-differentiation-of-a-primary-mucinous-tumor-of-the-ovary-and-an-ovarian-metastasis-of-a-low-grade-appendiceal-mucinous-neoplasm-lamn-a-series-of-seven-cases
#15
Elisa Schmoeckel, Thomas Kirchner, Doris Mayr
The differentiation between a primary mucinous ovarian neoplasm and an extra-ovarian metastasis in the ovary is often challenging in the histopathologic practice. Among various ovarian metastases from the gastro-intestinal tract the low-grade appendiceal mucinous neoplasm (LAMN) is an important differential diagnosis to consider particularly in case of pseudomyxoma peritonei. A newly recognized marker in the routine diagnostic of a mucinous neoplasm in the ovary is SATB2 (Special AT-rich sequence-binding protein 2)...
December 14, 2017: Pathology, Research and Practice
https://www.readbyqxmd.com/read/29483443/-conversion-surgery-for-pancreatic-head-cancer-with-peritoneal-dissemination-following-chemotherapy-for-two-years-a-case-report
#16
Yuuri Hatsuzawa, Masamichi Mizuma, Fuyuhiko Motoi, Tatsuo Hata, Masahiro Iseki, Tatsuyuki Takadate, Hideo Ohtsuka, Naoaki Sakata, Takanori Morikawa, Kei Nakagawa, Hiroki Hayashi, Takeshi Naitoh, Atsushi Kanno, Tooru Shimosegawa, Michiaki Unno
Here we report a case of pancreatic cancer(PC)with peritoneal dissemination, underwent conversion surgery following chemotherapy for 2 years. A5 5-year-old woman was referred to our hospital for treatment of PC. Abdominal CT scan revealed 3.0 cm of a pancreatic head tumor with abutment of the portal vein and the hepatic artery, classified as borderline resectable. Staging laparoscopy(SL)showed positive peritoneal cytology(CY). Gemcitabine(Gem)plus S-1 therapy(GS) was performed. Ten months after initial GS, SL revealed the disseminated nodule and positive CY...
February 2018: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://www.readbyqxmd.com/read/29469190/prognostic-significance-of-platelet-to-lymphocyte-ratio-in-patients-with-ovarian-cancer-a-meta-analysis
#17
Tian Chuan, Song Wei, Tian Xia, Sun Yong
BACKGROUND: The platelet-to-lymphocyte ratio (PLR) has been found to predict clinical outcomes in borderline ovarian tumors and the other genital neoplasms. However, its prognostic value in patients with ovarian cancer remains controversial. The aim of this study was to assess its prognostic value in ovarian cancer. METHODS: We searched MEDLINE, EMBASE and the Cochrane databases to identify studies evaluating the prognostic significance of pretreatment PLR in ovarian cancer...
February 22, 2018: European Journal of Clinical Investigation
https://www.readbyqxmd.com/read/29463093/utility-of-dwi-with-quantitative-adc-values-in-ovarian-tumors-a-meta-analysis-of-diagnostic-test-performance
#18
Shan Pi, Rong Cao, Jin Wei Qiang, Yan Hui Guo
Background Diffusion-weighted imaging (DWI) and quantitative apparent diffusion coefficient (ADC) values are widely used in the differential diagnosis of ovarian tumors. Purpose To assess the diagnostic performance of quantitative ADC values in ovarian tumors. Material and Methods PubMed, Embase, the Cochrane Library, and local databases were searched for studies assessing ovarian tumors using quantitative ADC values. We quantitatively analyzed the diagnostic performances for two clinical problems: benign vs...
January 1, 2018: Acta Radiologica
https://www.readbyqxmd.com/read/29403162/intraoperative-cytology-of-ovarian-neoplasms-with-an-attempt-to-grade-epithelial-tumors
#19
Sangita Bohara, Shyama Jain, Nita Khurana, Darilin M Shangpliang, Swapnil Agarwal, Gauri Gandhi
Background: Intraoperative cytology (IOC) is a simple and quick technique with excellent preservation of cellular details. In the present study, we have evaluated the role of IOC by various methods of smear preparation and compared it with frozen section diagnosis. A scoring system was followed for epithelial tumors for characterization and grading on the basis of cellularity, pattern, nuclear, cytoplasmic features, and background details. Materials and Methods: The study was conducted during a time span of 2 years in total 48 cases of ovarian tumors...
January 2018: Journal of Cytology
https://www.readbyqxmd.com/read/29397916/-fertility-preservation-contraception-and-menopause-hormone-therapy-in-women-treated-for-rare-ovarian-tumors-guidelines-from-the-french-national-network-dedicated-to-rare-gynaecological-cancer
#20
REVIEW
Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, François Planchamp, Lise Selleret, Christophe Pomel, Nathalie Chabbert-Buffet, Emile Daraï, Patricia Pautier, Florence Trémollières, Frederic Guyon, Roman Rouzier, Valérie Laurence, Nicolas Chopin, Cécile Faure-Conter, Enrica Bentivegna, Marie-Cécile Vacher-Lavenu, Catherine Lhomme, Anne Floquet, Isabelle Treilleux, Fabrice Lecuru, Sébastien Gouy, Elsa Kalbacher, Catherine Genestie, Thibault de la Motte Rouge, Gwenael Ferron, Mojgan Devouassoux-Shisheboran, Jean-Emmanuel Kurtz, Moise Namer, Florence Joly, Eric Pujade-Lauraine, Michael Grynberg, Denis Querleu, Philippe Morice, Anne Gompel, Isabelle Ray-Coquard
INTRODUCTION: Rare ovarian tumors include complex borderline ovarian tumors, sex-cord tumors, germ cell tumors, and rare epithelial tumors. Indications and modalities of fertility preservation, infertility management and contraindications for hormonal contraception or menopause hormone therapy are frequent issues in clinical practice. A panel of experts from the French national network dedicated to rare gynaecological cancers, and of experts in reproductive medicine and gynaecology have worked on guidelines about fertility preservation, contraception and menopause hormone therapy in women treated for ovarian rare tumors...
February 1, 2018: Bulletin du Cancer
keyword
keyword
74363
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"